Alps Group Receives Non‑Compliance Notice From Nasdaq
Alps Group Inc Publishes Clinical Safety, Tolerability and Effectiveness Data Supporting Advancement of Its Autologous NK Cell Pipeline Using an In-House Developed Culture Protocol
Alps Group Inc Announces Potential Pipeline Expansion Beyond CELESOME(+) Following Publication of Nebulized Human Umbilical Cord Mesenchymal Stem Cell Exosome Therapy
Alps Group Expands Its Exosome-Related Pipeline Beyond Its Previously Disclosed CELESOME(+) Program
Alps Group Inc Appoints Cheing Lye-Ping as Chief Financial Officer
Alps Group Appoints Cheing Lye-Ping CFO, Effective Jan. 5
Alps Group Inc (NASDAQ:ALPS) CEO Seng Tham's holdings dropped 12% in value as a result of the recent pullback
Alps Announces Closing of Business Combination with Globalink Investment Inc.
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.
